Virax Biolabs Group (NASDAQ: VRAX)
$0.97
(-2.5%)
-$0.03
Price as of June 11, 2025, 3:59 p.m. ET
Virax Biolabs Group Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Virax Biolabs Group Company Info
Virax Biolabs Group Ltd. is a holding company. It engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.